Related references
Note: Only part of the references are listed.Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study
Xiaoliang Liu et al.
Pediatric Rheumatology (2021)
Variation in the management of Kawasaki disease
Audrey Dionne et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2020)
The Impact of Changes in Clinical Guideline on Practice Patterns and Healthcare Utilizations for Kawasaki Disease in Japan
Yusuke Okubo et al.
FRONTIERS IN PEDIATRICS (2020)
JCS/JSCS 2020 Guideline on Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease
Ryuji Fukazawa et al.
CIRCULATION JOURNAL (2020)
Do cytokines correlate with refractory Kawasaki disease in children?
Ying Wang et al.
CLINICA CHIMICA ACTA (2020)
Procalcitonin levels predicting the infliximab response of immunoglobulin resistant Kawasaki disease
Yasutaka Nakashima et al.
CYTOKINE (2019)
Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease
Han Chan et al.
BMC PEDIATRICS (2019)
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease
Samantha C. Roberts et al.
CONTEMPORARY CLINICAL TRIALS (2019)
Impact of Socioeconomic Status on Outcomes of Patients with Kawasaki Disease
Audrey Dionne et al.
JOURNAL OF PEDIATRICS (2019)
Predictive value of serum procalcitonin for both initial and repeated immunoglobulin resistance in Kawasaki disease: a prospective cohort study
Shuran Shao et al.
PEDIATRIC RHEUMATOLOGY (2019)
Treatment Options for Resistant Kawasaki Disease
Linny Kimly Phuong et al.
PEDIATRIC DRUGS (2018)
Using the Electronic Medical Record to Correlate Kawasaki Disease Phenotypes With Clinical Outcomes
Preeti Jaggi et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2018)
How Should We Classify Kawasaki Disease?
Edoardo Marrani et al.
FRONTIERS IN IMMUNOLOGY (2018)
Describing Kawasaki shock syndrome: results from a retrospective study and literature review
Andrea Taddio et al.
CLINICAL RHEUMATOLOGY (2017)
Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease
Mitsuaki Kimura et al.
PEDIATRICS INTERNATIONAL (2017)
Efficacy of Four Scoring Systems in Predicting Intravenous Immunoglobulin Resistance in Children with Kawasaki Disease in a Children's Hospital in Beijing, North China
Ruixia Song et al.
JOURNAL OF PEDIATRICS (2017)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease A Scientific Statement for Health Professionals From the American Heart Association
Brian W. McCrindle et al.
CIRCULATION (2017)
Procalcitonin Impairs Endothelial Cell Function and Viability
Nana-Maria Wagner et al.
ANESTHESIA AND ANALGESIA (2017)
The prognostic role of abnormal liver function in IVIG unresponsiveness in Kawasaki disease: a meta-analysis
Ling Liu et al.
INFLAMMATION RESEARCH (2016)
Fever pattern and C-reactive protein predict response to rescue therapy in Kawasaki disease
Yu Nakagama et al.
PEDIATRICS INTERNATIONAL (2016)
Cardiovascular biomarkers in acute Kawasaki disease
Yuichiro Z. Sato et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Efficacy of Intravenous Immunoglobulin Combined with Prednisolone Following Resistance to Initial Intravenous Immunoglobulin Treatment of Acute Kawasaki Disease
Tohru Kobayashi et al.
JOURNAL OF PEDIATRICS (2013)
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial
Tohru Kobayashi et al.
LANCET (2012)
Treatment of Kawasaki Disease: Analysis of 27 US Pediatric Hospitals From 2001 to 2006
Mary Beth F. Son et al.
PEDIATRICS (2009)
Coronary artery involvement in children with Kawasaki disease - Risk factors from analysis of serial normalized measurements
Brian W. McCrindle et al.
CIRCULATION (2007)
Diagnosis, treatment, and long-term management of Kawasaki disease - A statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association
JW Newburger et al.
CIRCULATION (2004)
Share Paper
